A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma
Conditions: Unresectable Melanoma; Metastatic Melanoma Intervention: Drug: APX005M Sponsor: Apexigen, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials